Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol For The Evaluation of Primex's PGX Assay

NCT02336269 is registered in ClinicalTrials.gov with Primex Clinical Laboratories, Inc. as lead sponsor.

NCT NCT02336269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol For The Evaluation of Primex's PGX Assay
Lead sponsor
Primex Clinical Laboratories, Inc.
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2013
Completion date
October 31, 2019
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients on medications metabolized via cyp450